Related Experiment Videos
The DNA-binding efficiency of Sp1 is affected by redox changes
R Ammendola1, M Mesuraca, T Russo
1Dipartimento di Biochimica e Biotecnologie Mediche, Università di Napoli Federico II, Italy.
European Journal of Biochemistry
|October 1, 1994
Summary
Oxidative stress impairs Sp1 DNA binding in aging rats. This age-related decline in Sp1 transcription factor activity is reversible with antioxidants, suggesting a therapeutic target for age-related diseases.
Area of Science:
- Molecular Biology
- Aging Research
- Biochemistry
Background:
- Sp1 transcription factor DNA-binding efficiency decreases in aged rat tissues.
- Accumulation of reactive oxygen species (ROS) is characteristic of aging.
- The precise mechanism of Sp1 dysfunction in aging remains unclear.
Purpose of the Study:
- To investigate the impact of oxidative stress on Sp1 DNA-binding activity in aging.
- To determine if Sp1 itself or its cofactors are affected by oxidative damage.
- To explore the potential of antioxidants in restoring Sp1 function.
Main Methods:
- Electrophoretic mobility shift assays (EMSA) to assess DNA-binding activity.
- DNase I footprinting to map DNA-protein interactions.
- Purification of Sp1 protein from rat liver.
- In vitro treatment of nuclear extracts and purified Sp1 with hydrogen peroxide and dithiothreitol.
Main Results:
- Aged rat nuclear extracts showed reduced Sp1 DNA-binding, which was restored by dithiothreitol (DTT).
- Hydrogen peroxide treatment decreased Sp1 binding in young extracts, but DTT reversed this effect.
- Purified Sp1 from young rats bound aged nuclear extracts effectively, indicating Sp1 itself is functional.
- Oxidized purified Sp1 lost DNA-binding ability, fully restored by DTT.
Conclusions:
- Oxidative stress, not inherent aging of the Sp1 molecule, reduces Sp1 DNA-binding efficiency in aged rats.
- Sp1 protein is susceptible to oxidative damage, leading to impaired DNA binding.
- Antioxidant treatment, specifically with DTT, can restore Sp1 DNA-binding activity, suggesting a therapeutic strategy for age-related conditions.